Pathology News

The landscape of immunotherapy biomarkers is rapidly evolving, and future developments are likely to have an impact on patients and clinicians alike, said Kurt A. Schalper, MD, PhD, in a virtual presentation during the 5th Annual International Congress on Oncology and Pathology.

Researchers from the Yale Department of Immunology and Yale Cancer Center have recently developed a mouse model that displays enhanced human erythropoiesis and mature RBC survival to help them better study human blood disorders.

The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of applied research and technology in the life sciences.

Novel Gene Identified as Genetic Cause of Portal Hypertension

New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy.

YSM’s clinical, scientific, and educational efforts all overcame major challenges.

Yale lab develops revolutionary RNA vaccine for malaria

A case study in NPJ Precision Oncology used whole-exome sequencing (WES) to map out the genetic structure of a rare case of gliosarcoma.

A vaccine against malaria: five minutes with . . . Richard Bucala